Atlas.
Sign inStart free trial
VCYTNASDAQ · US

VERACYTE, INC.

Technology · Services-Medical Laboratories

TechnologyServices-Medical Laboratories
CEO
Marc Stapley
Founded
—
IPO Date
—
HQ
South San Francisco, CA, United States
Exchange
NASDAQ
Employees
n.a.

Share Price Performance

$59.85 ▲ 41.2%
Last (1 Jul 2026) · $60
Period High · $60.49
Period Low · $30.01
52W: $23.03 – $60.49

Key Metrics

Share Price
$59.85
+1.9% today
Market Cap
$4.7B
P / E
71.3x
EV / Revenue
8.4x
Revenue Growth
+16.0%
year-on-year
Gross Margin
+70.1%
Enterprise Value
$4.4B
52W High
$60.49
52W Low
$23.03
Avg Volume
1.1M
daily

Sources: SEC filings · Market data as of Jul 6, 2026

Shareholders' Structure
13 known institutional holders·$1.2B total on record·2026-Q1
BlackRock, Inc.
16.7%·$424M
Fmr LLC
9.8%·$250M
State Street Corp
6.4%·$162M
Dimensional Fund Advisors LP
3.6%·$93M
Geode Capital Management, LLC
2.5%·$63M
Bank Of America Corp
1.8%·$47M
Goldman Sachs Group Inc
1.6%·$41M
Northern Trust Corp
1.2%·$30M
Jpmorgan Chase & Co
0.6%·$15M
Point72 Asset Management, L.P.
0.6%·$16M
Invesco Ltd.
0.6%·$14M
Renaissance Technologies LLC
0.3%·$7M
Price T Rowe Associates Inc
0.1%·$2,930
Free Float
54.2%

Sources: SEC filings

Notes: % shown as share of total shares outstanding · Free float = shares outstanding minus all known 13F institutional holdings

What Atlas covers for VERACYTE, INC.
OverviewVERACYTE, INC. share price history (10 years), key market statistics, and institutional shareholder structure from SEC 13F-HR filings.Business ModelHow VERACYTE, INC. generates revenue — product and service segments, geographic breakdown, key operating metrics, and 10-year business evolution sourced from SEC filings.FinancialsVERACYTE, INC.'s complete financial history — 10 years of annual revenue, gross margins, operating income, net income, EPS, and free cash flow from SEC filings, plus 12 quarters of quarterly results.Management QualityVERACYTE, INC. executive team profiles, insider buying and selling from SEC Form 4, earnings call transcripts, and a track record of guidance delivery vs actual results.Risk FactorsVERACYTE, INC.'s annual risk disclosures from SEC filings — full text, 5-year evolution showing how risks have shifted, and year-on-year delta highlighting new and removed risks.NewsAI-synthesised news digest for VERACYTE, INC., updated regularly with key developments, earnings updates, product announcements, and material company events.SentimentInvestor sentiment for VERACYTE, INC. aggregated from X.com, Reddit, and Hacker News — discussion themes, Bull and Bear signals, and community analysis.Valuation & PeersVERACYTE, INC. valuation multiples — P/E, EV/Revenue, EV/EBITDA — compared against a curated set of industry peers using live data from SEC filings. Custom peer selection available.DCF BuilderBuild a discounted cash flow model for VERACYTE, INC. with 10 years of pre-filled revenue, margins, and cash flow data from SEC filings. Adjust growth rates, WACC, and terminal assumptions.Atlas AnalysisAtlas AI research synthesis for VERACYTE, INC. — business model, financial health, management quality, risk profile, and institutional ownership, grounded exclusively in SEC filings.

Unlock the full analysis

9-tab institutional research sourced directly from SEC filings. No tips, no scores — the same process professional investors use.

7-day free trial · Plus & Pro · No charge during trial